Inovio Pharmaceuticals (INO) Intangibles (2010 - 2023)
Inovio Pharmaceuticals (INO) recorded Intangibles of $2.05 million in Q1 2023, down 18.1% from $2.5 million a year earlier and down 3.9% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Intangibles (2010 - 2023) Analysis & Trends
At the end of FY2022, Inovio Pharmaceuticals reported Intangibles of $2.13 million, down 18.9% from FY2021.
- Annual Intangibles has declined for six straight years, with a five-year compound annual growth rate of -18.7% (FY2017 to FY2022).
- Across earlier years, Intangibles came in at $2.63 million in FY2021 (-16.5%), $3.15 million in FY2020 (-14.8%), $3.69 million in FY2019 (-22.4%) and $4.76 million in FY2018 (-20.8%).
- The Q1 2023 figure is the lowest quarterly Intangibles in data going back to Q4 2010.
- On a year-over-year basis, Intangibles has declined for 24 consecutive quarters, with an average decline of 17.4% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 14.8% (Q4 2020) and 22.4% (Q4 2019) over the last five years.
- Per Business Quant, the preceding three quarters came in at $2.13 million (Q4 2022), $2.25 million (Q3 2022) and $2.37 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 2.25 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 2.90 Mn |
| Mar 31, 2021 | 3.01 Mn |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | 3.30 Mn |
| Jun 30, 2020 | 3.42 Mn |
| Mar 31, 2020 | 3.56 Mn |
| Dec 31, 2019 | 3.69 Mn |
| Sep 30, 2019 | 3.96 Mn |
| Jun 30, 2019 | 4.23 Mn |
| Mar 31, 2019 | 4.49 Mn |
| Dec 31, 2018 | 4.76 Mn |
| Sep 30, 2018 | 5.03 Mn |
| Jun 30, 2018 | 5.29 Mn |
API Access
Inovio Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();